Literature DB >> 17115870

A preliminary investigation of rapid smoking as a lapse-responsive treatment for tobacco dependence.

Laura M Juliano1, Elisabeth J Houtsmuller, Maxine L Stitzer.   

Abstract

Lapses within the first 2 weeks of a smoking cessation attempt are strongly associated with a return to regular smoking (S. L. Kenford et al., 1994). Unfortunately, little is known about how to prevent an initial lapse from progressing to a full relapse, and presently there are no validated lapse-responsive therapeutic interventions. The present study tested the efficacy and feasibility of rapid smoking plus counseling as a novel lapse-responsive intervention. Sixty-seven participants enrolled in a smoking treatment program involving brief counseling and a 9-week course of bupropion. Beginning on the quit day, participants' smoking behavior was tracked daily for 14 days. Once an early smoking lapse was identified, participants were randomly assigned to receive either 3 sessions of rapid smoking plus counseling or no intervention (usual care). Consistent with previous research, participants who smoked during the first 2 weeks of the quit attempt had significantly poorer 6-month outcomes (3% abstinent) than did those who did not smoke (64% abstinent). Compared with early abstainers, early lapsers were more nicotine dependent and reported greater cravings and lower confidence in their ability to abstain from smoking during the first 48 hours of abstinence. As expected, rapid smoking produced a variety of aversive effects, including increased nausea, dizziness, and vomiting as well as sharply decreased cravings to smoke. However, rapid smoking did not improve abstinence outcomes relative to usual care. Although rapid smoking has been shown to be an effective treatment for initial smoking cessation, in this preliminary study the authors failed to demonstrate its effectiveness as a lapse-responsive treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115870     DOI: 10.1037/1064-1297.14.4.429

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  8 in total

Review 1.  Aversive smoking for smoking cessation.

Authors:  P Hajek; L F Stead
Journal:  Cochrane Database Syst Rev       Date:  2004

2.  Rapid smoking may not be aversive in schizophrenia.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Marc L Steinberg; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2012-02-07       Impact factor: 4.244

Review 3.  A systematic review of the relationships between craving and smoking cessation.

Authors:  Jennifer M Wray; Julie C Gass; Stephen T Tiffany
Journal:  Nicotine Tob Res       Date:  2013-01-04       Impact factor: 4.244

4.  Relapse prevention interventions for smoking cessation.

Authors:  Jonathan Livingstone-Banks; Emma Norris; Jamie Hartmann-Boyce; Robert West; Martin Jarvis; Emma Chubb; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2019-10-28

5.  Relapse prevention interventions for smoking cessation.

Authors:  Jonathan Livingstone-Banks; Emma Norris; Jamie Hartmann-Boyce; Robert West; Martin Jarvis; Peter Hajek
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

6.  Lower self-efficacy and greater depressive symptoms predict greater failure to recover from a single lapse cigarette.

Authors:  Christine Muench; Elizabeth J Malloy; Laura M Juliano
Journal:  J Consult Clin Psychol       Date:  2020-10

Review 7.  Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs.

Authors:  David Kalman; Sun Kim; Gregory DiGirolamo; David Smelson; Douglas Ziedonis
Journal:  Clin Psychol Rev       Date:  2010-02

8.  Effects of varenicline on abstinence and smoking reward following a programmed lapse.

Authors:  Erin A McClure; Ryan G Vandrey; Matthew W Johnson; Maxine L Stitzer
Journal:  Nicotine Tob Res       Date:  2012-05-09       Impact factor: 4.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.